Beyond Air, Inc.
corporate_fare Company Profile
Beyond Air, Inc. (NASDAQ:XAIR) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 35 items for XAIR at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-12, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 13 rated 8 or above. Recent SEC coverage for XAIR spans 10-Q, 424B3, 8-K, S-3.
Recent high-impact activity:
- Beyond Air 10-Q: $16.3M Six-Month Loss, Going-Concern Warning, $13.7M Cash
- Beyond Air Posts Wider-Than-Expected $3.49 Loss as Revenue Edges Past Estimates
- Beyond Air Preannounces Record $2.3M Quarterly Revenue, Up 30% Sequentially
- FDA Grants Breakthrough Device Designation to Beyond Air's LungFit GO for NTM-PD
- Beyond Air Sells NeuroNOS Stake for Equity and Milestone Payments
Financial Snapshot
Short Interest & Short Volume
4.79 days to coverFINRA reported short interest of 75,069 shares in XAIR as of the October 30, 2026 settlement, a 25.8% increase from the prior period — about 4.8 days to cover at its recent average daily volume. On November 20, 2026, 45.9% of XAIR volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Moderate riskFiling-implied dilution signals for XAIR, detected from its recent SEC filings.
Resale Registration Filed · Selling Stockholders Identified
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →